Marinus Pharmaceuticals Inc (MRNS)
0.3202
-0.01
(-4.45%)
USD |
NASDAQ |
Nov 05, 16:00
0.3202
0.00 (0.00%)
After-Hours: 18:22
Marinus Pharmaceuticals Total Assets (Quarterly): 87.08M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 87.08M |
| March 31, 2024 | 137.35M |
| December 31, 2023 | 170.91M |
| September 30, 2023 | 200.81M |
| June 30, 2023 | 201.20M |
| March 31, 2023 | 226.82M |
| December 31, 2022 | 259.52M |
| September 30, 2022 | 184.84M |
| June 30, 2022 | 109.38M |
| March 31, 2022 | 140.81M |
| December 31, 2021 | 136.84M |
| September 30, 2021 | 158.87M |
| June 30, 2021 | 124.99M |
| March 31, 2021 | 133.86M |
| December 31, 2020 | 150.46M |
| September 30, 2020 | 99.53M |
| June 30, 2020 | 113.44M |
| March 31, 2020 | 84.56M |
| December 31, 2019 | 98.84M |
| September 30, 2019 | 45.80M |
| June 30, 2019 | 58.96M |
| March 31, 2019 | 67.62M |
| Date | Value |
|---|---|
| December 31, 2018 | 75.23M |
| September 30, 2018 | 42.10M |
| June 30, 2018 | 48.69M |
| March 31, 2018 | 55.03M |
| December 31, 2017 | 60.67M |
| September 30, 2017 | 64.66M |
| June 30, 2017 | 22.10M |
| March 31, 2017 | 26.82M |
| December 31, 2016 | 31.45M |
| September 30, 2016 | 38.64M |
| June 30, 2016 | 46.16M |
| March 31, 2016 | 52.79M |
| December 31, 2015 | 59.65M |
| September 30, 2015 | 36.75M |
| June 30, 2015 | 41.04M |
| March 31, 2015 | 46.35M |
| December 31, 2014 | 50.21M |
| September 30, 2014 | 47.56M |
| June 30, 2014 | 9.479M |
| March 31, 2014 | 10.56M |
| December 31, 2013 | 11.82M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
84.56M
Minimum
Mar 2020
259.52M
Maximum
Dec 2022
148.43M
Average
137.35M
Median
Mar 2024
Total Assets (Quarterly) Benchmarks
| Chimerix Inc | 178.51M |
| Cellectar Biosciences Inc | 29.38M |
| Ocular Therapeutix Inc | 517.09M |
| Viking Therapeutics Inc | 937.89M |
| Jaguar Health Inc | 61.46M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 134.43M |
| Shareholders Equity (Quarterly) | -47.34M |
| Debt to Equity Ratio | -1.196 |
| Current Ratio | 2.283 |
| Net Debt Paydown Yield | 5.04% |